News & Events
Neuromonics- Industryâ??s First Meta-Analysis Comparing Tinnitus Treatments Shows Effective Results
19 / 05 / 2011
Sunshine Heart Announces Completion of Enrollment of 20 Patients for C-Pulse® Heart Assist System
05 / 04 / 2011
KaloBios Initiates Phase 1 Clinical Trial of KB004 in EphA3-Expressing Hematologic Malignancies
25 / 03 / 2011
ChemGenex to Align European and US Regulatory Strategies for Omacetaxine
05 / 01 / 2011
â?¢ Existing Marketing Authorization Application (MAA) for omacetaxine in T315I positive CML patients to be withdrawn â?¢ ChemGenex to submit a new MAA for omacetaxine in larger population of CML patients who have failed two or more tyrosine kinase inhibitors
ChemGenex Presents Updated Analysis at ASH on OMAPROâ?¢in CML Patients who Failed Two or Three Approved TKI Drugs
06 / 12 / 2010
â?¢ New analysis of clinical data indicates that OMAPROTM could offer a new treatment approach for CML Patients who fail to respond to TKI therapy â?¢ OMAPROTM induced durable major cytogenetic responses in 33% of chronic phase patients who failed currently approved drugs
Sunshine Heart successfully completes $9.5 million capital raising with close of non-renounceable rights offer
03 / 12 / 2010
Displaying records 376-400 of 703